D. E. Shaw & Co., Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $206,412 - $520,945	-982,916 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.32 - $0.67 $52,291 - $109,484	163,410 Added 19.94%	982,916 $522,000
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $84,474 - $156,276	140,790 Added 20.74%	819,506 $505,000
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $37,086 - $66,828	-36,719 Reduced 5.13%	678,716 $692,000
Q2 2021 Aug 16, 2021	BUY	$1.39 - $2.21 $242,044 - $384,833	174,133 Added 32.17%	715,435 $1.31 Million
Q1 2021 May 17, 2021	SELL	$1.27 - $3.42 $1.95 Million - $5.24 Million	-1,532,852 Reduced 73.9%	541,302 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $226,853 - $456,121	-241,334 Reduced 10.42%	2,074,154 $2.59 Million
Q3 2020 Nov 16, 2020	BUY	$1.5 - $9.38 $355,719 - $2.22 Million	237,146 Added 11.41%	2,315,488 $4.17 Million
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $3.96 Million - $6.94 Million	827,072 Added 66.1%	2,078,342 $17.4 Million
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $1.98 Million - $4.15 Million	576,117 Added 85.33%	1,251,270 $6.56 Million
Q4 2019 Feb 14, 2020	SELL	$4.29 - $5.64 $274,375 - $360,717	-63,957 Reduced 8.65%	675,153 $3.69 Million
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $1.03 Million - $1.5 Million	-212,024 Reduced 22.29%	739,110 $3.6 Million
Q2 2019 Aug 14, 2019	SELL	$6.6 - $7.8 $1.47 Million - $1.74 Million	-223,417 Reduced 19.02%	951,134 $6.59 Million
Q1 2019 May 15, 2019	BUY	$5.76 - $8.95 $3.68 Million - $5.72 Million	639,430 Added 119.49%	1,174,551 $8.16 Million
Q4 2018 Feb 14, 2019	BUY	$5.26 - $7.97 $2.81 Million - $4.26 Million	535,121 New	535,121 $3.13 Million
Q1 2018 May 15, 2018	SELL	$5.6 - $9.25 $66,449 - $109,760	-11,866 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$6.6 - $7.78 $5,016 - $5,912	-760 Reduced 6.02%	11,866 $84,000
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $72,599 - $97,851	12,626	12,626 $90,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$559,757
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$44,016
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$38,402
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account